Investing News and Commentary

Get today's latest stock market news

Top Story

A pipeline company, a pharmaceutical giant, and a real estate investment trust are top picks for income seekers this month.

Featured Articles

Recent Headlines

Will ConocoPhillips Raise Its Dividend in 2017?

One analyst believes that the oil giant plans to put more money into shareholders’ pockets by next year.

Burger King Tests "Meatatarian" Menu

Is the fast-food chain pushing the bounds of good taste with two flame-grilled beef patties, a crispy chicken patty, and six strips of bacon? Available only in New Zealand, for now.

Better Buy: Apple Inc. vs. Microsoft

Two tech giants facing very different challenges make for a tough decision for investors.

Teck Resources Ltd's Best Moves in 2016 So Far

Teck was heading toward a financial cliff at the start of the year, but it changed that in a big way.

5 Reasons to Buy Home Depot Inc. Stock Over Lowe’s Right Now

Why investors should be happy to pay a small premium to own the industry leader.

2 Companies Whose Revenue Could More Than Double By 2018

Yirendai and Momo could double their annual sales soon, but are they too hot to handle?

Apple May Have a New Way to Protect Your Smartphone

The company has filed for a patent to use the phone's own sensors and cameras to help protect it from theft.

Is Universal Orlando Repeating Disney World's Mistake?

Comcast's theme park resort is mixing things up with its annual passes, something that Disney did just before its attendance started to fall apart.

Spotify IPO Prospects Continue to Worsen

With a stock market debut clearly in the works, the music service must navigate a challenging state of affairs with its labels before it can move forward.

Why You Should Not Retire Now

As attractive as quitting your job might be, there are many reasons to think about waiting.

Home Depot Has Bought Back 20 Million Shares So Far in 2016. Should Investors Be Happy?

The home furnishing retailer's share buyback policy has helped deliver outsized returns to investors. Will the good times continue?

What's Up With Mylan's EpiPen Pricing?

An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation shares this week.

What Would the United States Look Like Without Nuclear Energy?

Some environmental groups want to see all nuclear power plants close their doors for good, but that wouldn't be such a great idea if we want to reduce emissions.

Solar Manufacturers Could Face Rough Road Ahead

Profitable operations so far in 2016 could turn south quickly if current forecasts are correct.

Why Monsanto Shouldn't Sell Itself

Management continues to consider all options with large multinational peers, but that may not be the best route forward for shareholders.

2 Clinical-Stage Biotech Stocks to Buy

Innovative drugs that could reshape patient treatment make Galapagos N.V. and Kite Pharma worth owning in portfolios.

Market Performance

S&P 500

Today -0.26%
1 Year 9.36%
5 Years 79.75%

More Foolish Content